Advertisement
Noticias de Forex
U.S. Economic Growth Slows Much More Than Expected To 1.1% In Q1
Preliminary data released by the Commerce Department on Thursday showed U.S. economic growth slowed by much more than expected in the first three months of 2023. The report said real gross domestic product increased by 1.1 percent in the first quarter after jumping by 2.6 percent in the fourth quarter of 2022. Economists had expected the pace of GDP growth to slow to 2.0 percent.
RTTNews |
hace 833
OSI Systems Q3 Results Miss Estimates; Reiterates FY23 Outlook
OSI Systems, Inc. (OSIS) reported on Thursday that net income for the third quarter doubled to $42.74 million or $2.41 per share from $21.81 million or $1.27 per share in the prior-year quarter. Excluding items, adjusted earnings were $1.43 per share, compared to $1.49 per share in the year-ago quarter.
RTTNews
|
hace 833
Medical Properties Trust Q1 Profit Plunges
Medical Properties Trust, Inc. (MPW) reported Thursday a first-quarter net income attributable to stockholders of $32.79 million or $0.05 per share, sharply lower than $631.68 million or $1.05 per share prior-year quarter.
RTTNews
|
hace 833
U.S. GDP Growth Slows Much More Than Expected In Q1
Preliminary data released by the Commerce Department on Thursday showed U.S. economic growth slowed by much more than expected in the first three months of 2023.
RTTNews
|
hace 833
U.S. Weekly Jobless Claims Unexpectedly Dip
First-time claims for U.S. unemployment benefits unexpectedly declined in the week ended April 22nd, according to a report released by the Labor Department on Thursday.
RTTNews
|
hace 833
Dollar Climbs After U.S. GDP Data
U.S. weekly jobless claims for the week ended April 22 and GDP data for the first quarter have been published at 8:30 am ET Thursday. The greenback climbed against its major counterparts after the data.
RTTNews
|
hace 833
CTS Q1 Results Top Estimates; Maintains FY23 Outlook
CTS Corp. (CTS) reported Thursday that net earnings for the first quarter decreased to $18.34 million or $0.58 per share from $20.24 million or $0.63 per share in the prior-year quarter. Excluding items, adjusted earnings were $0.61 per share, compared to $0.67 per share in the year-ago quarter.
RTTNews
|
hace 833
more news
Dollar Mixed Ahead Of U.S. GDP Data
U.S. weekly jobless claims for the week ended April 22 and GDP data for the first quarter are due at 8:30 am ET Thursday. The greenback traded mixed against its major counterparts before the data. While it fell against the yen and the pound, it rose against the euro and the franc.
RTTNews
|
hace 833
Eurozone Economic Sentiment Improves Modestly On Manufacturing Rebound
Eurozone economic confidence improved marginally in April as the weakness in industry was more than offset by improvement in confidence among consumers and services providers. The economic sentiment index, or ESI, rose to 99.3 in April from 99.2 in the previous month, data from the European Commission showed Thursday.
RTTNews
|
hace 833
Bay Street Likely To Open On Positive Note
Higher Canadian and U.S. futures and steady commodity prices point to a positive start for the Canadian market on Thursday.
RTTNews
|
hace 833
Interpublic Q1 Results Top Estimates
Interpublic Group of Cos., Inc. (IPG) reported Thursday that net income available to IPG common stockholders for the first quarter declined to $126.0 million or $0.33 per share from $159.4 million or $0.40 per share in the prior-year quarter.
RTTNews
|
hace 833
Baxter International Q1 Results Top Estimates; Boosts FY23 Adj. EPS Outlook
Health care company Baxter International Inc. (BAX) reported Thursday that net income attributable to Baxter for the first quarter declined to $44 million or $0.09 per share from $71 million or $0.14 per share in the prior-year quarter. Excluding items, adjusted earnings for the quarter were $0.59 per share, compared to $0.93 per share in the year-ago quarter.
RTTNews
|
hace 833
Bristol-Myers Squibb Affirms FY23 Outlook; Q1 Adj. EPS Tops Estimates
While reporting financial results for the first quarter on Thursday, biopharmaceutical company Bristol-Myers Squibb Co. (BMY) affirmed its adjusted earnings and revenue growth guidance for the full-year 2023.
RTTNews
|
hace 833
Stay up to date!
Add Noticias to your browser
Add To Chrome
